Cargando…
Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth
The major challenges we are facing in cancer therapy with paclitaxel (PTX) are the drug resistance and severe side effects. Massive efforts have been made to overcome these clinical challenges by combining PTX with other drugs. In this study, we reported the first preclinical data that praziquantel...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520897/ https://www.ncbi.nlm.nih.gov/pubmed/23251610 http://dx.doi.org/10.1371/journal.pone.0051721 |